In contrast, glucocerobrosidase (GBA) gene variants have been associated to poorer DBS outcomes in terms of cognitive decline and non‐motor symptom burden, but not response of motor symptoms to DBS.85, 86. The gene discussed is GBA1; the disease is Mental deterioration.